Defence Therapeutics Inc (DTC.CX)
0.51
+0.01
(+2.00%)
CAD |
CNSX |
Aug 25, 16:00
Defence Therapeutics EPS Diluted (Quarterly) : -0.0502 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0502 |
| December 31, 2025 | -0.0275 |
| September 30, 2025 | -0.0128 |
| June 30, 2025 | -0.0212 |
| March 31, 2025 | -0.0193 |
| December 31, 2024 | -0.0174 |
| September 30, 2024 | -0.0133 |
| June 30, 2024 | -0.0296 |
| March 31, 2024 | -0.0298 |
| December 31, 2023 | -0.1887 |
| September 30, 2023 | -0.0501 |
| June 30, 2023 | -0.04 |
| March 31, 2023 | -0.0346 |
| December 31, 2022 | -0.0527 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.0461 |
| June 30, 2022 | -0.0595 |
| March 31, 2022 | -0.0469 |
| December 31, 2021 | -0.0539 |
| September 30, 2021 | -0.0431 |
| June 30, 2021 | -0.05 |
| March 31, 2021 | -0.0198 |
| December 31, 2020 | -0.0127 |
| September 30, 2020 | -0.0012 |
| June 30, 2020 | -0.0136 |
| March 31, 2020 | -0.0055 |
| December 31, 2019 | -0.0001 |
| September 30, 2019 | -0.0002 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spectral Medical, Inc. | 0.0011 |
| Resverlogix Corp. | -0.0256 |
| Theratechnologies, Inc. | -0.1271 |
| COSCIENS Biopharma, Inc. | -0.267 |
| Restart Life Sciences Corp. | -0.0058 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.962M |
| Total Expenses (Quarterly) | 2.962M |
| Enterprise Value | 37.16M |
| Earnings Yield | -21.90% |
| Normalized Earnings Yield | -18.24 |